Health-care firms turn to drugmaker executives as businesses converge

“If you are changing the dynamic that much your executive team needs to understand the manufacturer side of the industry, the provider side of the industry and the insurer side of the industry,” said Yogesh Bahl, a managing director at AlixPartners.